StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Earnings

Soligenix's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Soligenix's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2016ended Jun 30, 2016Aug 12, 2016after the close–––Filing
Q2 FY2013ended Jun 30, 2013Aug 21, 2013after the close–––Filing
Q1 FY2013ended Mar 31, 2013May 8, 2013after the close–––Filing
Q1 FY2012ended Mar 31, 2012May 15, 2012during market hours–––Filing
Q2 FY2011ended Jun 30, 2011Aug 12, 2011during market hours–––Filing
Q1 FY2011ended Mar 31, 2011May 13, 2011after the close–––Filing
Q4 FY2010ended Dec 31, 2010Mar 29, 2011after the close–––Filing
Q3 FY2010ended Sep 30, 2010Nov 16, 2010during market hours–––Filing
Q2 FY2010ended Jun 30, 2010Aug 13, 2010before the open–––Filing
Q4 FY2009ended Dec 31, 2009Apr 1, 2010during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Soligenix has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Soligenix puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Soligenix filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. News
  5. News
  6. News
  7. Update
  8. Update
  9. News
  10. News
  11. News
  12. Update
  13. Update
  14. Update
  15. News

See a number that looks wrong?